Submit Deal

PFENEX INC

Summary

Pfenex is a development and licensing biotechnology company with commercial products focused on leveraging its proprietary protein production platform.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 349 M

Avg. Deal Size£ 349 M

Market Context

Senior Management

Jason Grenfell-Gardner
Chairman

Sort

10 Aug 2020|United States|Biotechnology

Target: PFENEX INC

Bidder: LIGAND PHARMACEUTICALS INC

7 Service Providers

3 Target | 4 Bidder

13 Dealmakers

5 Target | 8 Bidder

£ 349 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy